Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial.

Cairns JA, Wittes J, Wyse DG, Pogue J, Gent M, Hirsh J, Marler J, Pritchett EL.

Am Heart J. 2008 Jan;155(1):33-41. Epub 2007 Nov 26. Review.

PMID:
18082486
[PubMed - indexed for MEDLINE]
2.

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.

Active Steering Committee; ACTIVE Investigators, Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J.

Am Heart J. 2006 Jun;151(6):1187-93.

PMID:
16781218
[PubMed - indexed for MEDLINE]
3.

Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).

Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ.

Stroke. 2008 May;39(5):1482-6. doi: 10.1161/STROKEAHA.107.500199. Epub 2008 Mar 6.

PMID:
18323500
[PubMed - indexed for MEDLINE]
Free Article
4.

Clopidogrel plus aspirin vs oral anticoagulation for atrial fibrillation: the ACTIVE W trial.

DeSilvey DL.

Am J Geriatr Cardiol. 2006 Sep-Oct;15(5):326-7. No abstract available.

PMID:
16957455
[PubMed - indexed for MEDLINE]
5.

A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.

Zhao Y, Grambsch PM, Neaton JD.

Clin Trials. 2007;4(2):140-53.

PMID:
17456513
[PubMed - indexed for MEDLINE]
6.

Data and safety monitoring during randomized controlled trials of nursing interventions.

Artinian NT, Froelicher ES, Vander Wal JS.

Nurs Res. 2004 Nov-Dec;53(6):414-8.

PMID:
15586138
[PubMed - indexed for MEDLINE]
7.

Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.

Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL.

Clin Trials. 2007;4(3):207-17.

PMID:
17715246
[PubMed - indexed for MEDLINE]
8.

Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta-analysis of the literature.

Dolan G, Smith LA, Collins S, Plumb JM.

Curr Med Res Opin. 2008 May;24(5):1459-72. doi: 10.1185/030079908X297349 . Epub 2008 Apr 9. Review.

PMID:
18402715
[PubMed - indexed for MEDLINE]
9.

DSMB case study: decision making when a similar clinical trial is stopped early.

Hillman DW, Louis TA.

Control Clin Trials. 2003 Feb;24(1):85-91.

PMID:
12559646
[PubMed - indexed for MEDLINE]
10.

Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.

Tangelder MJ, Frison L, Weaver D, Wilcox RG, Bylock A, Emanuelsson H, Held P, Oldgren J.

Am Heart J. 2008 Feb;155(2):382-7. doi: 10.1016/j.ahj.2007.08.035.

PMID:
18215612
[PubMed - indexed for MEDLINE]
11.

A flexible futility monitoring method with time-varying conditional power boundary.

Ying Zhang, Clarke WR.

Clin Trials. 2010 Jun;7(3):209-18. doi: 10.1177/1740774510369686. Epub 2010 Apr 27.

PMID:
20423927
[PubMed - indexed for MEDLINE]
12.

[Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].

Meinertz T.

Internist (Berl). 2007 Aug;48(8):874-5. German. No abstract available.

PMID:
17628764
[PubMed - indexed for MEDLINE]
13.

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range.

Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S; ACTIVE W Investigators.

Circulation. 2008 Nov 11;118(20):2029-37. doi: 10.1161/CIRCULATIONAHA.107.750000. Epub 2008 Oct 27.

PMID:
18955670
[PubMed - indexed for MEDLINE]
Free Article
14.

Current controversies in data monitoring for clinical trials.

Pocock SJ.

Clin Trials. 2006;3(6):513-21.

PMID:
17170035
[PubMed - indexed for MEDLINE]
15.

Futility approaches to interim monitoring by data monitoring committees.

Demets DL.

Clin Trials. 2006;3(6):522-9. Review.

PMID:
17170036
[PubMed - indexed for MEDLINE]
16.

Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.

Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Fox KA, Granger CB, Jolly S, Rupprecht HJ, Widimsky P, Yusuf S; CURRENT-OASIS 7 Steering Committee.

Am Heart J. 2008 Dec;156(6):1080-1088.e1. doi: 10.1016/j.ahj.2008.07.026. Epub 2008 Nov 1.

PMID:
19033002
[PubMed - indexed for MEDLINE]
17.

Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.

Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C.

Med Klin (Munich). 2008 Sep 15;103(9):628-32. doi: 10.1007/s00063-008-1101-4. Epub 2008 Sep 24.

PMID:
18813885
[PubMed - indexed for MEDLINE]
18.

Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.

Hart RG, Bhatt DL, Hacke W, Fox KA, Hankey GJ, Berger PB, Hu T, Topol EJ; CHARISMA Investigators.

Cerebrovasc Dis. 2008;25(4):344-7. doi: 10.1159/000118380. Epub 2008 Feb 27.

PMID:
18303254
[PubMed - indexed for MEDLINE]
19.

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators.

Ann Intern Med. 2009 Mar 17;150(6):379-86.

PMID:
19293071
[PubMed - indexed for MEDLINE]
20.

Critical review of prasugrel for formulary decision makers.

Schafer JA, Kjesbo NK, Gleason PP.

J Manag Care Pharm. 2009 May;15(4):335-43. Review.

PMID:
19422273
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk